This document is a patent application published by the European Patent Office (EPO) for a novel biaryl ring compound with immunomodulatory properties, filed by Shanghai Longwood Biopharmaceuticals Co., Ltd. The application, identified as EP2024125662A1, was published on March 18, 2026, and covers various International Patent Classification (IPC) codes related to organic chemistry and pharmaceutical applications, including A61P 35/00 (antineoplastic) and A61P 37/02 (immunomodulators).

This publication represents a new intellectual property filing and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future developments in the immunomodulator space. Companies operating in the pharmaceutical sector, particularly those involved in drug development and manufacturing, should be aware of this patent application as it may impact their research, development, and commercialization strategies in the future, especially within the designated European states.